Clovis Oncology, Inc.
CLVS
CLVS was delisted on the 20th of December, 2022.
109 hedge funds and large institutions have $1.43B invested in Clovis Oncology, Inc. in 2013 Q2 according to their latest regulatory filings, with 109 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Barclays
London,
United Kingdom
| $128K | +$86.1K | +1,914 | New |
|
102
Bessemer Group
Woodbridge,
New Jersey
| $90K | +$60.7K | +1,350 | New |
|
|
TRCT
103
Tower Research Capital (TRC)
New York
| $77K | +$51.7K | +1,150 | New |
|
104
Ameriprise
Minneapolis,
Minnesota
| $60K | +$40.5K | +901 | New |
|
105
Citigroup
New York
| $21K | +$14.3K | +318 | New |
|
106
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $17K | +$11.2K | +250 | New |
|
107
Loomis, Sayles & Company
Boston,
Massachusetts
| $11.4K | +$7.67M | +170,483 | New |
|
|
PMFA
108
Plante Moran Financial Advisors
Southfield,
Michigan
| $4K | +$2.56K | +57 | New |
|
|
EFSCE
109
Enterprise Financial Services Corp (EFSC)
Clayton,
Missouri
| $4K | +$2.88K | +64 | New |
|
CLVS Hedge Fund Activity: Q2 2013 in Review
109 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q2 2013, worth a combined $1.43B.
Buyers outnumbered sellers: 109 funds opened new CLVS positions and 0 closed out — a net gain of 109 holders — while 0 added to existing stakes and 0 trimmed.
- 109 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $1.43B of Clovis Oncology, Inc. stock for Q2 2013.
- 109 funds opened new Clovis Oncology, Inc. positions in Q2 2013 and 0 closed out, a net change of +109 holders.
Based on aggregated 13F filings for Q2 2013.